Anti-MHC Class II antibody [6C6],Abcam,AB55152

Anti-MHC Class II antibody [6C6] (ab55152) is a House Mouse Monoclonal antibody and is validated for use in Flow Cyt, ICC/IF, IHC-P, WB. Anti-MHC Class II antibody [6C6] (ab55152) has been cited over 33 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality validation processes ensure Anti-MHC Class II antibody [6C6] (ab55152) has high sensitivity and specificity. Anti-MHC Class II antibody [6C6] (ab55152) specifically detects MHC Class II (UniProt ID: P04440; Molecular weight: 26kDa) and is sold in 100 ug selling sizes. MHC Class II molecules are primarily expressed on professional antigen-presenting cells (APCs) like dendritic cells, macrophages, and B cells. In oncology, MHC Class II molecules play a crucial role by presenting exogenous antigens to CD4+ T cells, which is essential for initiating and regulating the immune response against tumors. This product was changed from ascites to tissue culture supernatant on 13 th Feb 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Host

Mouse

Reactivity

Human

Application

Flow Cyt, ICC/IF, IHC-P, WB

Platform ID

BAB947390765

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-MHC Class II antibody [6C6]
Cat. No.AB55152
HostMouse
IsotypeIgG2a
ReactivityHuman
ApplicationFlow Cyt, ICC/IF, IHC-P, WB
ClonalityMonoclonal
Clone Number6C6
Concentration0.5 mg/mL Batch dependent concentration
ImmunogenRecombinant Full Length Protein corresponding to Human HLA-DPB1.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. See full target information HLA-DPB1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.